AgomAb Therapeutics NV Insider Trades
NASDAQ: AGMBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 9.08 0.00%
Last 12 months
- Purchases
- 7 · $266.67K
- Sales
- 0 · $0
- Shares bought / sold
- 31.00K / 0
- Net activity
- Net buying $266,670
AgomAb Therapeutics NV insider activity
Over the last 12 months, AgomAb Therapeutics NV insiders reported 7 transactions on SEC Form 4: 7 open-market purchases and 0 sales. Insiders bought $266,670 and sold $0 worth of stock, for net insider buying of $266,670. The most recent filing shows Knotnerus Tim Jasper (Chief Executive Officer) buying 5,000 shares at $8.70 on Oct 6, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put AGMB's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
AGMB insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 6, 2026 | Epstein David RDirector | Buy | 5,000 | $43.50K | Form 4 |
| Oct 6, 2026 | Kemula Pierre Thadee VictorChief Financial Officer | Buy | 2,000 | $17.08K | Form 4 |
| Oct 6, 2026 | Kemula Pierre Thadee VictorChief Financial Officer | Buy | 5,000 | $42.85K | Form 4 |
| Oct 6, 2026 | Kemula Pierre Thadee VictorChief Financial Officer | Buy | 3,000 | $26.01K | Form 4 |
| Oct 6, 2026 | Knotnerus Tim JasperChief Executive Officer | Buy | 5,000 | $43.50K | Form 4 |
| Oct 5, 2026 | Epstein David RDirector | Buy | 5,000 | $42.85K | Form 4 |
| Oct 5, 2026 | Knotnerus Tim JasperChief Executive Officer | Buy | 6,000 | $50.88K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4